Short-term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience
Journal Title: Heart Research – Open Journal - Year 2017, Vol 4, Issue 3
Abstract
Objective: The aim of the study was to test both efficacy and safety of empaglifozin in type 2 diabetic out patients followed-up within a single institution. Materials and Methods: One hundred seventy-eight consecutive patients treated with empaglifozin for 6 months were compared to 356 fully matched control patients on alternative drugs: side effects were monitored and changes from baseline were evaluated for body weight, body mass index (BMI), blood pressure, circulating glucose, HbA1c, uric acid, triglycerides, total, high density lipoprotein (HDL) and low density lipoprotein (LDL)-cholesterol levels, as well as creatinine clearance rate. The 10-year Cardiovascular Risk score (10-y CV-RS) was also assessed in all patients according to the cryogenic underground observatory for rare events (CUORE) calculation charts. Weight, BMI, systolic and diastolic blood pressure, as well as, HbA1c, glucose, cholesterol, triglyceride and uric acid levels, significantly decreased after treatment, along with the 10-y CV-RS which is in fact strongly related to the above. Results: Virtually no changes were observed in creatinine clearance rate and HDL levels. 45% patients reported polyuria, 15% genital itching, 8% genital infections, 12% urinary tract infections, no volume depletion or keto-acidosis episodes were described. Conclusion: In conclusion, in diabetic patients experiencing no previous major cardiovascular events, empaglifozin significantly improved all cardiovascular risk factors, including glucose control, and the 10-y CV-RS. Moreover it was well tolerated, so that no treatment discontinuation was needed even in case of urinary tract infections.
Authors and Affiliations
Sandro Gentile
Keywords
Related Articles
- EP ID EP557960
- DOI 10.17140/HROJ-4-141
- Views 123
- Downloads 0
Nicorandil: What is Beyond the Anti-Anginal Action?
Incidence of Contrast Induced Nephropathy (CIN) among ischemic heart disease patients subjected to coronary catheterization is highly dependent on the kidney function before contrast media administration and relevant ris...
Coronary CT Angiography in Coronary Artery Disease: from Diagnosis to Prevention
Coronary CT angiography has emerged as reliable imaging tool for the diagnosis of coronary artery disease. Coronary CT angiography has the ability to demonstrate excellent visualization of anatomical changes in coronary...
Patient Quality Measures: The Necessary Paradigm Shifts in Medicine
Improving patient quality measures is a complex task. It involves more than simply telling caregivers to adopt new practices. Rather, it uses current research and tools to bring about creating changes in workplace attitu...
Effects of Iterative Reconstruction on the Diagnostic Assessment of Coronary Calcium Scores
Coronary Artery Calcium (CAC) score is a widely used indicator to determine disease severity and predict the risk of severe cardiac events. However, radiation dose associated with coronary CT scanning for CAC scoring rai...
E-Care Project: A Promising E-Platform for Optimizing Management of Chronic Heart Failure and Other Chronic Diseases
Monitoring patients with heart failure by using telemedicine systems is a potential means for optimizing the management of these patients. The E-care project is developing an “intelligent” communicative platform enabling...